Whether you accept it, avoid it or live somewhere in between, insurance coverage has become a defining issue for our profession. Patients increasingly expect to use their benefits, practitioners want to be compensated fairly for their time and expertise, and the system itself remains – at best – fragmented. The encouraging news is that coverage has expanded in meaningful ways. The challenging news is that reimbursement, across the board, remains inadequate.
Sheldon Li, PhD
Dr. Sheldon Li is the chairman of ActiveHerb Technology, Inc. (www.ActiveHerbWholesale.com). He received his PhD in molecular biology with honor from the University of Zurich and conducted cutting-edge research at Yale, UCSD and the Scripps Research Institute. He has made numerous original scientific discoveries, which have been published in prestigious scientific journals like Nature. His seminal discoveries are featured in the Molecular Biology of the Gene, an influential textbook studied by biomedical students in the U.S. and around the world. He sees TCM is undervalued by the mainstream science and now devotes himself to communicating the enormous value of TCM to the public.